- Home
- STKE vs ATRA Comparison
STKE vs ATRA Comparison
Compare STKE & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STKE | ATRA |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.3M | 39.1M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | STKE | ATRA |
|---|---|---|
| Price | $1.31 | $4.96 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 157.7K | 128.6K |
| Earning Date | 01-01-0001 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.93 |
| Revenue | N/A | ★ $128,940,000.00 |
| Revenue This Year | $15.56 | N/A |
| Revenue Next Year | $44.24 | N/A |
| P/E Ratio | ★ N/A | $1.87 |
| Revenue Growth | N/A | ★ 1404.02 |
| 52 Week Low | $1.18 | $3.92 |
| 52 Week High | $7.75 | $19.15 |
Technical Indicators
Market Signals| Indicator | STKE | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 41.18 |
| Support Level | $1.18 | $4.06 |
| Resistance Level | $2.80 | $5.71 |
| Average True Range (ATR) | 0.13 | 0.45 |
| MACD | 0.03 | 0.38 |
| Stochastic Oscillator | 40.00 | 52.03 |
Price Performance
Historical ComparisonAbout STKE Sol Strategies Inc.
Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).